BioNTech's Potential Winners Beyond Its COVID Vaccine

Motley Fool

24 Jan 2021 0 shares 2 views

Motley Fool

Published 24 Jan 2021

The biotech's pipeline includes many promising candidates.

European Commission Authorizes Second Vaccine Against COVID-19

Eurasia Review 07 Jan 2021

The European Commission has granted a conditional marketing authorisation (CMA) for the COVID‑19 vaccine developed by Moderna,..

Reports of possible allergic reactions to the COVID-19 vaccines produced by Pfizer-BioNTech and Moderna, both recently approved for..

Eurasia Review 03 Jan 2021

The World Health Organization (WHO) has granted emergency use validation for the Pfizer-BioNTech Covid-19 vaccine, opening the door..

Mid-Day 01 Jan 2021